This is the authors' abstract. We don't add key points for this paper.
Adoptive T-cell immunotherapy is a promising approach to cancer therapy. Stem cell memory T (T SCM ) cells have been proposed as a class of long-lived and highly proliferative memory T cells. CD8 + T SCM cells can be generated in vitro from naive CD8 + T cells via Wnt signalling; however, methods do not yet exist for inducing T SCM cells from activated or memory T cells. Here, we show a strategy for generating T SCM -like cells in vitro (iT SCM cells) from activated CD4 + and CD8 + T cells in mice and humans by coculturing with stromal cells that express a Notch ligand. iT SCM cells lose PD-1 and CTLA-4 expression, and produce a large number of tumour-specific effector cells after restimulation. This method could therefore be used to generate antigen-specific effector T cells for adoptive immunotherapy.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kondo et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: